Cargando…
Recurrent Vulvovaginal Candidiasis: An Immunological Perspective
Vulvovaginal candidiasis (VVC) is a widespread vaginal infection primarily caused by Candida albicans. VVC affects up to 75% of women of childbearing age once in their life, and up to 9% of women in different populations experience more than three episodes per year, which is defined as recurrent vul...
Autores principales: | Rosati, Diletta, Bruno, Mariolina, Jaeger, Martin, ten Oever, Jaap, Netea, Mihai G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074770/ https://www.ncbi.nlm.nih.gov/pubmed/31972980 http://dx.doi.org/10.3390/microorganisms8020144 |
Ejemplares similares
-
An Exaggerated Monocyte-Derived Cytokine Response to Candida Hyphae in Patients With Recurrent Vulvovaginal Candidiasis
por: Rosati, Diletta, et al.
Publicado: (2020) -
Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
por: Ge, Gai, et al.
Publicado: (2022) -
Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis
por: Rosentul, Diana C., et al.
Publicado: (2014) -
Clinical challenges in diagnosis and treatment of recurrent
vulvovaginal candidiasis
por: Neal, Chemen M, et al.
Publicado: (2022) -
Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp
por: Grant, Leah M., et al.
Publicado: (2022)